ScholarIQanswers from OpenAlex & ORCID
Henk G. van der Poel
ResearcherPublications, citations & collaboration network
Henk G. van der Poel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Henk G. van der Poel have?
ScholarIQindexed works
Henk G. van der Poel has 786 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Henk G. van der Poel have?
ScholarIQcitation count
Henk G. van der Poel has 31,601 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Henk G. van der Poel?
ScholarIQh-index
Henk G. van der Poel has an h-index of 76 in OpenAlex.
What is the i10-index of Henk G. van der Poel?
ScholarIQi10-index
Henk G. van der Poel has an i10-index of 354 in OpenAlex.
What is the ORCID of Henk G. van der Poel?
ScholarIQorcid
The ORCID for Henk G. van der Poel is on the source record.
What is the OpenAlex record for Henk G. van der Poel?
ScholarIQopenalex
The OpenAlex for Henk G. van der Poel is on the source record.
What are the most-cited papers on Henk G. van der Poel?
ScholarIQmost cited works
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy
Vincenzo Ficarra, Giacomo Novara, Raymond C. Rosen, Walter Artibani, Peter R. Carroll, Anthony J. Costello, Mani Menon, Francesco Montorsi, Vipul Patel, Jens-Uwe Stolzenburg, Henk G. van der Poel, Timothy G. Wilson, Filiberto Zattoni, Alexandre Mottrie
Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy
Vincenzo Ficarra, Giacomo Novara, Thomas E. Ahlering, Anthony J. Costello, James A. Eastham, Markus Graefen, Giorgio Guazzoni, Mani Menon, Alexandre Mottrie, Vipul Patel, Henk G. van der Poel, Raymond C. Rosen, Ashutosh Tewari, Timothy G. Wilson, Filiberto Zattoni, Francesco Montorsi
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial
Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret, Antony Cicco, F. Kleinclauss, Henk G. van der Poel, Christian G. Stief, Jens Rassweiler, Georg Salomon, Eduardo Solsona, Antonio Alcaraz, Teuvo T. L. Tammela, Derek J. Rosario, F. Gómez-Veiga, Göran Ahlgren, Fawzi Benzaghou, B. Gaillac, Billy Amzal, F.M.J. Debruyne, Gaëlle Fromont, Christian Gratzke, Mark Emberton
Best Practices in Robot-assisted Radical Prostatectomy: Recommendations of the Pasadena Consensus Panel
Francesco Montorsi, Timothy G. Wilson, Raymond C. Rosen, Thomas E. Ahlering, Walter Artibani, Peter R. Carroll, Anthony J. Costello, James A. Eastham, Vincenzo Ficarra, Giorgio Guazzoni, Mani Menon, Giacomo Novara, Vipul Patel, Jens‐Uwe Stolzenburg, Henk G. van der Poel, H. Van Poppel, Alexandre Mottrie
Prostate cancer reactivates developmental epigenomic programs during metastatic progression
Mark M. Pomerantz, Xintao Qiu, Yanyun Zhu, David Y. Takeda, Wenting Pan, Sylvan C. Baca, Alexander Gusev, Keegan Korthauer, Tesa Severson, Gavin Ha, Srinivas R. Viswanathan, Ji-Heui Seo, Holly M. Nguyen, Baohui Zhang, Bogdan Paşaniuc, Claudia Giambartolomei, Sarah Abou Alaiwi, Connor Bell, Edward O’Connor, Matthew Chabot, David R. Stillman, Rosina T. Lis, Alba Font‐Tello, Lewyn Li, Paloma Cejas, Andries M. Bergman, Joyce Sanders, Henk G. van der Poel, Simon A. Gayther, Kate Lawrenson, Marcos A. Fonseca, Jessica Reddy, Rosario I. Corona, Gleb Martovetsky, Brian Egan, Toni K. Choueiri, Leigh Ellis, Isla P. Garraway, Gwo‐Shu Mary Lee, Eva Corey, Henry W. Long, Wilbert Zwart, Matthew L. Freedman